BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30774370)

  • 41. [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells
    Deng R; Zhang F; Lei F; Liu W; Liu S; Wang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1615-1621. PubMed ID: 33243752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
    Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
    Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
    Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
    Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis
    Li P; Xing J; Zhang J; Jiang J; Liu X; Zhao D; Zhang Y
    J Adv Res; 2020 Nov; 26():123-135. PubMed ID: 33133688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-1β-Mediated Up-Regulation of WT1D via miR-144-3p and Their Synergistic Effect with NF-κB/COX-2/HIF-1α Pathway on Cell Proliferation in LUAD.
    Wu C; Li X; Zhang D; Xu B; Hu W; Zheng X; Zhu D; Zhou Q; Jiang J; Wu C
    Cell Physiol Biochem; 2018; 48(6):2493-2502. PubMed ID: 30121641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-143-5p suppresses breast cancer progression by targeting the HIF-1α-related GLUT1 pathway.
    Xu J; Li X; Zhang P; Luo J; Mou E; Liu S
    Oncol Lett; 2022 May; 23(5):147. PubMed ID: 35350590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role and regulatory mechanism of HIF-1α in myocardial injury in rats undergoing cardiopulmonary bypass.
    Zhang M; Zhou N; Cao F; Liu W; Yuan H; Huang G
    Acta Cardiol; 2023 Dec; 78(10):1070-1080. PubMed ID: 37470433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis.
    Hou G; Yang J; Tang J; He Y
    Cell Cycle; 2021 Jan; 20(2):179-193. PubMed ID: 33459113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA SNHG1 alleviates OGD induced injury in BMEC via miR-338/HIF-1α axis.
    Yang X; Zi XH
    Brain Res; 2019 Jul; 1714():174-181. PubMed ID: 30414401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA.
    Chen M; Wei X; Shi X; Lu L; Zhang G; Huang Y; Hou J
    Cancer Biol Med; 2021 Mar; 18(2):587-603. PubMed ID: 33710813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knockdown of HIF1A-AS2 suppresses TRIM44 to protect cardiomyocytes against hypoxia-induced injury.
    Luo F; Wu Y; Zhu L; Zhang J; Liu Y; Jia W
    Cell Biol Int; 2020 Jul; 44(7):1523-1534. PubMed ID: 32222118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evolving role of long noncoding RNA HIF1A-AS2 in diabetic retinopathy: a cross-link axis between hypoxia, oxidative stress and angiogenesis via MAPK/VEGF-dependent pathway.
    Atef MM; Shafik NM; Hafez YM; Watany MM; Selim A; Shafik HM; Safwat El-Deeb O
    Redox Rep; 2022 Dec; 27(1):70-78. PubMed ID: 35285425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway.
    Wang Y; Huang Y; Liu H; Su D; Luo F; Zhou F
    Biochem Biophys Res Commun; 2019 Jun; 514(1):44-50. PubMed ID: 31014670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
    Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.